plicamycin has been researched along with mitoxantrone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holguin, MH; Morgan, CD | 1 |
| Boichuk, S; Brown, MF; Cuevas, R; Debiec-Rychter, M; Duensing, A; Korzeniewski, N; Kuan, SF; Lee, DJ; Makielski, KR; Mehalek, KR; Parry, JA; Schöffski, P; Seneviratne, DS; Taguchi, T; Wozniak, A; Zewe, J | 1 |
| Thorne, J | 1 |
3 other study(ies) available for plicamycin and mitoxantrone
| Article | Year |
|---|---|
Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.
Topics: Antibiotics, Antineoplastic; Antibodies, Blocking; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Bleomycin; Dactinomycin; Dose-Response Relationship, Drug; Humans; Immunophenotyping; Lectins, C-Type; Mannitol; Mitomycin; Mitoxantrone; Plicamycin; Spectrometry, Fluorescence; Stress, Physiological; T-Lymphocytes; Thymidine | 2002 |
Unbiased compound screening identifies unexpected drug sensitivities and novel treatment options for gastrointestinal stromal tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Drug Screening Assays, Antitumor; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Mice; Mice, Nude; Mitoxantrone; Plicamycin; Topoisomerase II Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 2014 |
Drug repurposing identifies therapeutic agents for gastrointestinal stromal tumors.
Topics: Antineoplastic Agents; Drug Discovery; Drug Repositioning; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastrointestinal Tract; Humans; Mitoxantrone; Plicamycin; Protein Synthesis Inhibitors; Sp1 Transcription Factor; Topoisomerase II Inhibitors | 2014 |